A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer
2010

Chemotherapy and Radiotherapy for Tonsil Cancer

Sample size: 41 publication 10 minutes Evidence: moderate

Author Information

Author(s): R Prestwich, K Kancherla, D Oksuz Colpan, D Williamson, K E Dyker, C Coyle, M Sen

Primary Institution: St. James's Institute of Oncology, St. James's University Hospital, Leeds Teaching Hospitals, Leeds, West Yorkshire, UK

Hypothesis

Can induction chemotherapy followed by chemoradiotherapy improve outcomes for patients with locally advanced tonsillar cancer?

Conclusion

Cisplatin-based induction and concurrent chemoradiotherapy provides excellent tumour control with acceptable toxicity for patients with locally advanced tonsillar cancer.

Supporting Evidence

  • 85% of patients received 2 or more cycles of induction chemotherapy.
  • 78% of patients had a clinical response after induction chemotherapy.
  • 91% local and regional control rate in complete responders at 3 years.
  • 75% three-year progression-free survival rate in all patients.

Takeaway

Doctors used chemotherapy and radiation to treat patients with tonsil cancer, and most of them got better without needing surgery.

Methodology

Retrospective analysis of 41 patients treated with induction chemotherapy followed by chemoradiotherapy.

Potential Biases

The study may not represent outcomes in a broader patient population as it was conducted in a single center.

Limitations

The study did not assess the prevalence of HPV in the patient cohort, which limits comparisons with other studies.

Participant Demographics

Median age was 55 years, with 68% male participants.

Statistical Information

P-Value

0.004

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1748-717X-5-121

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication